CTLA4 and non-small cell lung carcinoma: Better survivability for the early-stage OSCC patients suggests that CTLA4 might be overexpressed on the surface of early-stage tumor cells, as have been observed on cancer cell lines as well as in non-small cell lung carcinoma [61, 62].